SERINO, Maria Luisa
 Distribuzione geografica
Continente #
NA - Nord America 4.628
EU - Europa 1.884
AS - Asia 920
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 7
OC - Oceania 3
SA - Sud America 2
Totale 7.452
Nazione #
US - Stati Uniti d'America 4.621
IT - Italia 710
CN - Cina 498
UA - Ucraina 335
TR - Turchia 256
DE - Germania 242
PL - Polonia 163
GB - Regno Unito 130
SG - Singapore 117
SE - Svezia 96
FI - Finlandia 82
SM - San Marino 40
FR - Francia 28
BE - Belgio 16
ID - Indonesia 15
CZ - Repubblica Ceca 14
VN - Vietnam 12
RU - Federazione Russa 8
IN - India 7
IR - Iran 7
EG - Egitto 5
IE - Irlanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CA - Canada 4
EU - Europa 4
MX - Messico 3
NL - Olanda 3
RO - Romania 3
CH - Svizzera 2
DK - Danimarca 2
ES - Italia 2
KE - Kenya 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
CO - Colombia 1
JP - Giappone 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
TH - Thailandia 1
TW - Taiwan 1
Totale 7.452
Città #
Woodbridge 658
Fairfield 536
Chandler 483
Jacksonville 404
Houston 290
Ann Arbor 261
Ashburn 254
Seattle 231
Wilmington 224
Warsaw 162
Cambridge 157
Izmir 150
Nanjing 112
Ferrara 111
Beijing 107
Princeton 86
Milan 85
Boardman 71
Singapore 63
Shanghai 57
New York 56
San Diego 46
Bremen 38
Shenyang 34
Dearborn 32
Hebei 30
Nanchang 26
Changsha 23
Jiaxing 20
Redwood City 20
Düsseldorf 17
Jinan 15
Mountain View 15
Rome 15
Brussels 14
Jakarta 14
Brno 13
Falls Church 13
Tianjin 13
Bologna 12
Dong Ket 12
Los Angeles 12
Des Moines 11
Meda 11
Guangzhou 10
Kunming 10
Washington 10
Auburn Hills 9
Napoli 9
London 8
Orange 8
Augusta 7
Domagnano 7
Helsinki 7
Ansbach 6
Brescia 6
Changchun 6
Ningbo 6
Norwalk 6
Pavia 6
Pescara 6
Redmond 6
San Marino 6
Ardabil 5
Duncan 5
Hangzhou 5
Munich 5
Naples 5
Calvisano 4
Ferrara di Monte Baldo 4
Monmouth Junction 4
San Mateo 4
Addison 3
Altopascio 3
Davoli 3
Hefei 3
Lodi 3
Marino 3
Monticello Conte Otto 3
Padova 3
Sheffield 3
Siracusa 3
Torre del Greco 3
Walnut 3
Zhengzhou 3
Acton 2
Albizzate 2
Auckland 2
Bangalore 2
Cairo 2
Carpi 2
Casoria 2
Chicago 2
Council Bluffs 2
Damanhur 2
Dogana 2
Dublin 2
Florence 2
Frankfurt am Main 2
Hounslow 2
Totale 5.263
Nome #
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 409
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 215
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 159
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 154
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 149
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 149
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 137
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 132
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 125
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 123
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 122
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 119
null 118
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 116
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 116
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 114
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 113
A photometric assay for factor-XIII in chronic hepatopathies. 111
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 110
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 109
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 107
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 106
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: Identification of 23 new mutations 106
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 106
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 106
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 105
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 103
null 102
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 99
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 98
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers 98
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 95
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 94
Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients 92
null 91
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 87
null 85
Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation 85
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 82
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 80
null 80
Una "rete" per proteggere il cuore. (FAR 2013) 79
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 78
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 74
A web-based clinical record 'xl'Emofilia® 'for outpatients with haemophilia and allied disorders in the region of Emilia-Romagna: Features and pilot use 74
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 73
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 71
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 70
A modified functional Global test to measure PC, PS activities and the APC-Resistance phenotype. 70
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 68
High protein C plasma levels affect the response to exogenous preactivated protein C and enhance that to endogenous Protac-mediated activated protein C. 67
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities. 67
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 67
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 66
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 65
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 64
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 63
Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. 63
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 62
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 62
null 61
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 60
FXIII-A V34L and FXIII-B H95R gene polymorphism: effects on the efficacy of thrombolytic therapy in acute myocardial infarction. 59
Thrombotic risk in thalassemic patients. 59
Malattie emorragiche vascolari. 56
A Common mutation in the gene for coagulation factor XIII-A (V34L): a risk factor for hemorrhagic disorders it is protective against atherothrombotic diseases. 55
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 51
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 51
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 51
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 50
Bassi livelli di Proteina S e Resistenza alla Proteina C attivata in dieci famiglie italiane. 50
null 49
Detection of a Protein C Gene Mutation Present in the Asymptomatic and not in the Thrombosis-Prone Lineage. 49
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 46
MTHFR Specific Activity, Homocysteine and Folate Levels in Subjects with Thermolabile MTHFR (C677T) 45
Conteggio piastrinico e terapia sostitutiva in un paziente con Malattia di von Willebrand tipo 2B. 45
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 45
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 45
Sui rapporti tra anticorpi anticardiolipina e ß-2-glicoproteina I plasmatica. 42
Common Factor XIII Gene Polymorphisms In Venous Leg Ulcers. 41
Piastrinopenia da anticorpi anticardiolipina: remissione persistente dopo splenectomia. 39
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 35
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 35
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 35
Treatment outcome and postoperative complications of mucogingival surgery in a case of type I von Willebrand disease 32
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 28
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 24
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 23
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes 22
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 19
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 18
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? 16
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 14
GRB 130427A: a Nearby Ordinary Monster 14
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 7
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 6
Totale 7.587
Categoria #
all - tutte 28.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 230
Totale 29.146

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.549 262 45 44 197 121 194 127 155 110 162 81 51
2020/20211.243 98 103 46 131 97 139 51 140 46 181 151 60
2021/2022837 30 77 46 41 65 36 37 51 28 86 104 236
2022/20231.093 106 104 21 131 189 156 60 109 111 9 63 34
2023/2024605 53 69 26 26 72 94 28 49 9 21 25 133
2024/202569 69 0 0 0 0 0 0 0 0 0 0 0
Totale 7.587